ro13-9904 and Uterine-Neoplasms

ro13-9904 has been researched along with Uterine-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for ro13-9904 and Uterine-Neoplasms

Article	Year
[Study on tissue transfer of ceftriaxone in the field of obstetrics and gynecology]. The Japanese journal of antibiotics, 1984, Volume: 37, Issue:12 Ceftriaxone (Ro 13-9904, CTRX) was studied about the tissue transfer in the gyneco-obstetric field and the following results were obtained. The transfer of CTRX into the uterine tissues and adnexa was favorable following an intravenous injection with 1 g. The mean serum level 1 hour after administration was 123.3 micrograms/ml while the tissue level ranged from 26 to 48 micrograms/g. The level in the pelvic dead space exudate reached a peak 3 to 6 hours after administration and got higher than the serum level at 5 to 6 hours. Topics: Cefotaxime; Ceftriaxone; Exudates and Transudates; Female; Genitalia, Female; Humans; Injections, Intravenous; Pelvis; Tissue Distribution; Uterine Cervical Neoplasms; Uterine Neoplasms	1984

Article

Year

[Study on tissue transfer of ceftriaxone in the field of obstetrics and gynecology].

The Japanese journal of antibiotics, 1984, Volume: 37, Issue:12

Ceftriaxone (Ro 13-9904, CTRX) was studied about the tissue transfer in the gyneco-obstetric field and the following results were obtained. The transfer of CTRX into the uterine tissues and adnexa was favorable following an intravenous injection with 1 g. The mean serum level 1 hour after administration was 123.3 micrograms/ml while the tissue level ranged from 26 to 48 micrograms/g. The level in the pelvic dead space exudate reached a peak 3 to 6 hours after administration and got higher than the serum level at 5 to 6 hours.

Topics: Cefotaxime; Ceftriaxone; Exudates and Transudates; Female; Genitalia, Female; Humans; Injections, Intravenous; Pelvis; Tissue Distribution; Uterine Cervical Neoplasms; Uterine Neoplasms

1984